Hiroyuki Watanabe

6.6k total citations
226 papers, 5.4k citations indexed

About

Hiroyuki Watanabe is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hiroyuki Watanabe has authored 226 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 51 papers in Physiology and 41 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hiroyuki Watanabe's work include Alzheimer's disease research and treatments (51 papers), Radiopharmaceutical Chemistry and Applications (32 papers) and Neuroscience and Neuropharmacology Research (17 papers). Hiroyuki Watanabe is often cited by papers focused on Alzheimer's disease research and treatments (51 papers), Radiopharmaceutical Chemistry and Applications (32 papers) and Neuroscience and Neuropharmacology Research (17 papers). Hiroyuki Watanabe collaborates with scholars based in Japan, Thailand and Indonesia. Hiroyuki Watanabe's co-authors include Masahiro Ono, Hideo Saji, Haruo Seto, Tomohisa Kuzuyama, Hiroyuki Kimura, Shunji Takahashi, Shimpei Iikuni, Jiro Tsuji, Ichiro Minami and Satoshi Kawata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Chemical Physics.

In The Last Decade

Hiroyuki Watanabe

209 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Watanabe Japan 36 1.8k 1.2k 1.0k 993 763 226 5.4k
Michael Gajhede Denmark 43 3.6k 2.0× 571 0.5× 619 0.6× 494 0.5× 265 0.3× 173 6.6k
K. Peter R. Nilsson Sweden 48 4.1k 2.3× 735 0.6× 1.6k 1.5× 3.5k 3.6× 527 0.7× 189 8.6k
Marie‐Isabel Aguilar Australia 47 4.7k 2.7× 823 0.7× 395 0.4× 649 0.7× 389 0.5× 213 7.0k
Karl Gademann Switzerland 48 5.5k 3.1× 3.7k 3.2× 614 0.6× 626 0.6× 1.0k 1.3× 203 10.1k
James S. Nowick United States 46 4.4k 2.5× 2.3k 1.9× 626 0.6× 1.4k 1.4× 338 0.4× 156 6.4k
Lin Jiang United States 30 4.0k 2.3× 452 0.4× 991 1.0× 1.5k 1.6× 278 0.4× 52 5.6k
Fei Mao China 40 2.5k 1.4× 1.7k 1.4× 377 0.4× 431 0.4× 702 0.9× 170 7.1k
Guanghong Wei China 47 4.1k 2.3× 837 0.7× 1.3k 1.3× 2.7k 2.7× 299 0.4× 190 6.7k
Kasper P. Kepp Denmark 34 1.4k 0.8× 445 0.4× 1.0k 1.0× 1.2k 1.2× 395 0.5× 121 4.7k
Emmanuel A. Theodorakis United States 45 2.6k 1.5× 2.6k 2.3× 1.5k 1.5× 388 0.4× 839 1.1× 154 7.5k

Countries citing papers authored by Hiroyuki Watanabe

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Watanabe more than expected).

Fields of papers citing papers by Hiroyuki Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Watanabe. The network helps show where Hiroyuki Watanabe may publish in the future.

Co-authorship network of co-authors of Hiroyuki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Watanabe. A scholar is included among the top collaborators of Hiroyuki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Watanabe. Hiroyuki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Hiroyuki, et al.. (2025). Novel BODIPY-Based Fluorescent Probes with Improved Aqueous Solubility for Selective Detection of Soluble Aβ Aggregates. ACS Chemical Neuroscience. 16(21). 4257–4266.
2.
Watanabe, Hiroyuki, et al.. (2025). Impact of Albumin-Binding Moieties on Structure–Affinity–Pharmacokinetic Relationships of Novel FAP-Targeting Radioligands. Molecular Pharmaceutics. 22(10). 5989–5998.
3.
Watanabe, Hiroyuki, et al.. (2024). Development of Triphenylmethane Dyes for In Vivo Fluorescence Imaging of Aβ Oligomers. ACS Chemical Neuroscience. 15(11). 2233–2242. 5 indexed citations
4.
Watanabe, Hiroyuki, et al.. (2024). Development of Novel Bimodal Agents Based on Near-Infrared BODIPY-Conjugated Hoechst Derivatives for Combined Use in Auger Electron and Photodynamic Cancer Therapy. ACS Pharmacology & Translational Science. 7(5). 1395–1403. 2 indexed citations
5.
Watanabe, Hiroyuki, et al.. (2023). Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical Communications. 59(7). 928–931. 8 indexed citations
6.
Watanabe, Hiroyuki, et al.. (2022). Synthesis and Evaluation of 18F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model. ACS Chemical Neuroscience. 13(20). 2982–2990. 10 indexed citations
7.
Iikuni, Shimpei, et al.. (2022). Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands. ACS Medicinal Chemistry Letters. 13(10). 1642–1647. 4 indexed citations
8.
9.
Iikuni, Shimpei, et al.. (2021). Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. Journal of Medicinal Chemistry. 64(18). 13429–13438. 27 indexed citations
10.
Watanabe, Hiroyuki, et al.. (2021). Chalcone Analogue as New Candidate for Selective Detection of α-Synuclein Pathology. ACS Chemical Neuroscience. 13(1). 16–26. 13 indexed citations
11.
Watanabe, Hiroyuki, et al.. (2021). Structure–Activity and Brain Kinetics Relationships of 18F-Labeled Benzimidazopyridine Derivatives as Tau PET Tracers. ACS Medicinal Chemistry Letters. 12(2). 262–266. 6 indexed citations
12.
Iikuni, Shimpei, et al.. (2021). Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent. Chemical Communications. 57(52). 6432–6435. 18 indexed citations
13.
14.
Watanabe, Hiroyuki, Yoichi Shimizu, Shimpei Iikuni, et al.. (2020). Development of Novel PET Imaging Probes for Detection of Amylin Aggregates in the Pancreas. Molecular Pharmaceutics. 17(4). 1293–1299. 4 indexed citations
15.
Iikuni, Shimpei, et al.. (2020). Synthesis and evaluation of indium-111-labeled imidazothiadiazole sulfonamide derivative for single photon emission computed tomography imaging targeting carbonic anhydrase-IX. Bioorganic & Medicinal Chemistry Letters. 30(14). 127255–127255. 14 indexed citations
16.
Iikuni, Shimpei, et al.. (2020). Synthesis and evaluation of novel technetium-99m-hydroxamamide complex based on imidazothiadiazole sulfonamide targeting carbonic anhydrase-IX for tumor imaging. Bioorganic & Medicinal Chemistry Letters. 30(22). 127596–127596. 7 indexed citations
17.
Ono, Masahiro, Hiroyuki Watanabe, Yoichi Shimizu, et al.. (2018). Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging. Bioorganic & Medicinal Chemistry. 26(12). 3352–3358. 12 indexed citations
18.
Watanabe, Hiroyuki, Hideo Saji, & Masahiro Ono. (2018). Novel fluorescence probes based on the chalcone scaffold for in vitro staining of β-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 28(19). 3242–3246. 11 indexed citations
19.
20.
Iikuni, Shimpei, Masahiro Ono, Hiroyuki Watanabe, et al.. (2016). Novel Bivalent 99mTc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy. PLoS ONE. 11(9). e0163969–e0163969. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Gajhede Breakdown of academic impact, for papers by K. Peter R. Nilsson Breakdown of academic impact, for papers by Marie‐Isabel Aguilar Breakdown of academic impact, for papers by Karl Gademann Breakdown of academic impact, for papers by James S. Nowick Breakdown of academic impact, for papers by Lin Jiang Breakdown of academic impact, for papers by Fei Mao Breakdown of academic impact, for papers by Guanghong Wei Breakdown of academic impact, for papers by Kasper P. Kepp Breakdown of academic impact, for papers by Emmanuel A. Theodorakis
Rankless by CCL
2026